Mesenteric Infiltration in Ovarian Cancer
- Conditions
- Ovary Cancer
- Interventions
- Diagnostic Test: Computed Tomography
- Registration Number
- NCT06331130
- Brief Summary
To evaluate if CT features at diagnosis in patients with HGSOC can be used to build an Artificial Intelligence model capable of discerning the pathological involvement of the mesentery, assessing the potential impediments for an optimal debulking surgery and predicting the development of resistance to platinum based chemotherapeutic agents.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 510
- Women with confirmed HGSOC wiht mesenteric involvment
- Age > 18 years
- FIGO STAGE IIIB-IV
- Primary diagnosis
- Signed informed consent
- Non-serous high grade epithelial ovarian cancer (serous low grade, mucinous, clear cell carcinoma, endometrioid or non-epithelial ovarian cancer)
- Early stage disease (I and II stage)
- CT scan not available
- Non-primary diagnosis or patient subjected to neoadjuvant chemotherapy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Prospective cohort Computed Tomography Patients affected by High Grade Seruous Ovarian Cancer with mesenteric infiltration confirmed by diagnostic laparoscopy Retrospective cohort Computed Tomography Patients affected by High Grade Seruous Ovarian Cancer with mesenteric infiltration confirmed by diagnostic laparoscopy, from January 2021 to December 2023
- Primary Outcome Measures
Name Time Method Preoperative Artificial Intelligence assisted CT-based evaluation 1 year Preoperative Artificial Intelligence assisted CT-based prediction of patients with suboptimal debulking at surgery due to diffuse mesenteric disease or mesenteric retraction.
- Secondary Outcome Measures
Name Time Method Evaluation of the Radiologist Assessment of the CT 1 year Identification of mesenteric infiltration from CT images using Artificial Intelligence at a comparable performance with human/radiologist assessment.
Prediction of Platinum Resistance 1 year AI-assisted CT-based prediction of patients who will develop platinum resistance
Prediction of Progression Free Survival (PFS) and Overall Survival (OS) 2 years Prediction of Progression Free Survival (PFS) and Overall Survival (OS) with Artificial Intelligence
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Advanced Radiology Center
🇮🇹Roma, Italy